Next Article in Journal
The Role of Nurses and the Facilitators and Barriers in Diabetes Care: A Mixed Methods Systematic Literature Review
Previous Article in Journal
Relationship between Academic Stress, Physical Activity and Diet in University Students of Education
Previous Article in Special Issue
de novo Blood Biomarkers in Autism: Autoantibodies against Neuronal and Glial Proteins

Speech-Stimulating Substances in Autism Spectrum Disorders

Research Division, Autism Immunology Unit of Maracaibo, Maracaibo 4001, Venezuela
Department of Biology, Faculty of Sciences, University of Zulia, Maracaibo 4001, Venezuela
Catedra libre de Autismo, Universidad del Zulia, Maracaibo 4001, Venezuela
Italian Group for Studying Autism—GISA, 25018 Brescia, Italy
Biomedical Centre for Autism Research and Treatment, 70126 Bari, Italy
Department of Cellular and Integrative Physiology, School of Medicine, University of Texas Health Science Center San Antonio, San Antonio, TX 78229, USA
Department of Experimental Medicine, University of Campania, 80138 Napoli, Italy
Centre for Autism-La Forza del Silenzio, 81036 Caserta, Italy
Author to whom correspondence should be addressed.
Behav. Sci. 2019, 9(6), 60;
Received: 24 May 2019 / Revised: 10 June 2019 / Accepted: 11 June 2019 / Published: 12 June 2019
Autism spectrum disorder (ASD) is characterized by the core domains of persistent deficits in social communication and restricted-repetitive patterns of behaviors, interests, or activities. A heterogeneous and complex set of neurodevelopmental conditions are grouped in the spectrum. Pro-inflammatory events and immune system dysfunctions are cellular and molecular events associated with ASD. Several conditions co-occur with ASD: seizures, gastro-intestinal problems, attention deficit, anxiety and depression, and sleep problems. However, language and speech issues are key components of ASD symptoms current therapies find difficult to face. Several speech-stimulating substances have been shown to be effective in increasing speech ability in ASD subjects. The need for large clinical trials to determine safety and efficacy is recommended. View Full-Text
Keywords: autism spectrum disorder; speech; language; nutrition autism spectrum disorder; speech; language; nutrition
Show Figures

Figure 1

MDPI and ACS Style

Castillo, M.A.; Urdaneta, K.E.; Semprún-Hernández, N.; Brigida, A.L.; Antonucci, N.; Schultz, S.; Siniscalco, D. Speech-Stimulating Substances in Autism Spectrum Disorders. Behav. Sci. 2019, 9, 60.

AMA Style

Castillo MA, Urdaneta KE, Semprún-Hernández N, Brigida AL, Antonucci N, Schultz S, Siniscalco D. Speech-Stimulating Substances in Autism Spectrum Disorders. Behavioral Sciences. 2019; 9(6):60.

Chicago/Turabian Style

Castillo, María A., Kendy E. Urdaneta, Neomar Semprún-Hernández, Anna L. Brigida, Nicola Antonucci, Stephen Schultz, and Dario Siniscalco. 2019. "Speech-Stimulating Substances in Autism Spectrum Disorders" Behavioral Sciences 9, no. 6: 60.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop